GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE330nnn/GSE330657/primaryOK200TranscriptomicsMus musculusExpression profiling by arrayhttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE330657GEOGSEfalseActivation of tumor-specific CD8+ T cells prior to radiopharmaceutical therapy improves anti-tumor responsePreviously, we found that the presence and activation of tumor-specific CD8+ T cells prior to radiopharmaceutical therapy (RPT), 90Y-NM600, enhanced anti-tumor responses. Here, we aimed to evaluate changes in the tumor immune microenvironment after E.G7-OVA tumor-bearing mice received adoptive transfer of naïve OT-I CD8+ T cells, followed by a DNA vaccine, and 90Y-NM600. Tumors were collected 7 and 14 days following 90Y-NM600, isolated total RNA, and performed gene expression analysis using the nCounter Mouse Immune Exhaustion Panel on the nCounter MAX system.2026/06/19GSE330657GSM9729951GSM9729940GSM9729950GSM9729942GSM9729941GSM9729944GSM9729943GSM9729946GSM9729945GSM9729948GSM9729937GSM9729947GSM9729939GSM9729938GSM972994932403330657Mus musculus